Aflac (NYSE:AFL) Major Shareholder Sells $1,519,826.00 in Stock

Aflac Incorporated (NYSE:AFL) major shareholder Post Holdings Co. Ltd. Japan sold 14,200 shares of the firm’s stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $107.03, for a total value of $1,519,826.00. Following the transaction, the insider owned 52,018,600 shares of the company’s stock, valued at $5,567,550,758. This trade represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Post Holdings Co. Ltd. Japan also recently made the following trade(s):

• On Monday, March 23rd, Post Holdings Co. Ltd. Japan sold 15,000 shares of Aflac stock. The stock was sold at an average price of $106.78, for a total transaction of $1,601,700.00.
• On Friday, March 20th, Post Holdings Co. Ltd. Japan sold 16,800 shares of Aflac stock. The stock was sold at an average price of $106.47, for a total transaction of $1,788,696.00.
• On Thursday, March 19th, Post Holdings Co. Ltd. Japan sold 10,100 shares of Aflac stock. The shares were sold at an average price of $107.41, for a total transaction of $1,084,841.00.
• On Wednesday, March 18th, Post Holdings Co. Ltd. Japan sold 12,200 shares of Aflac stock. The shares were sold at an average price of $108.43, for a total transaction of $1,322,846.00.
• On Tuesday, March 17th, Post Holdings Co. Ltd. Japan sold 15,700 shares of Aflac stock. The stock was sold at an average price of $109.77, for a total transaction of $1,723,389.00.
• On Friday, March 13th, Post Holdings Co. Ltd. Japan sold 17,400 shares of Aflac stock. The stock was sold at an average price of $109.14, for a total transaction of $1,899,036.00.
• On Thursday, March 12th, Post Holdings Co. Ltd. Japan sold 17,900 shares of Aflac stock. The shares were sold at an average price of $109.60, for a total transaction of $1,961,840.00.
• On Wednesday, March 11th, Post Holdings Co. Ltd. Japan sold 18,100 shares of Aflac stock. The stock was sold at an average price of $109.53, for a total transaction of $1,982,493.00.
• On Tuesday, March 10th, Post Holdings Co. Ltd. Japan sold 19,000 shares of Aflac stock. The stock was sold at an average price of $110.47, for a total value of $2,098,930.00.
• On Monday, March 9th, Post Holdings Co. Ltd. Japan sold 17,300 shares of Aflac stock. The shares were sold at an average price of $109.62, for a total value of $1,896,426.00.

Aflac Trading Up 1.5%

NYSE:AFL opened at $108.05 on Tuesday. The firm has a market cap of $55.67 billion, a PE ratio of 15.71, a price-to-earnings-growth ratio of 3.49 and a beta of 0.66. The stock has a fifty day moving average price of $111.10 and a 200 day moving average price of $110.38. Aflac Incorporated has a 12-month low of $96.95 and a 12-month high of $119.32. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, February 4th. The financial services provider reported $1.57 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a return on equity of 14.35% and a net margin of 21.24%.The company had revenue of $4.28 billion for the quarter, compared to analyst estimates of $4.45 billion. During the same period in the previous year, the firm earned $1.57 earnings per share. The company’s revenue for the quarter was down 9.6% compared to the same quarter last year. Sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on AFL shares. Morgan Stanley set a $120.00 target price on shares of Aflac in a research note on Monday, December 15th. Barclays set a $101.00 price target on shares of Aflac and gave the stock an “underweight” rating in a research note on Thursday, January 8th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Aflac in a report on Monday, December 22nd. Wells Fargo & Company increased their price objective on shares of Aflac from $109.00 to $118.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 25th. Finally, Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a report on Saturday, February 28th. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $112.00.

Institutional Investors Weigh In On Aflac

Hedge funds and other institutional investors have recently made changes to their positions in the business. True Wealth Design LLC lifted its stake in Aflac by 188.5% during the third quarter. True Wealth Design LLC now owns 225 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 147 shares during the last quarter. Quarry LP purchased a new position in Aflac in the fourth quarter valued at approximately $25,000. Nalls Sherbakoff Group LLC acquired a new stake in Aflac during the fourth quarter worth approximately $29,000. Navalign LLC acquired a new stake in Aflac during the fourth quarter worth approximately $32,000. Finally, Darwin Wealth Management LLC purchased a new stake in shares of Aflac during the 2nd quarter worth approximately $33,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.